Connect with us

Hi, what are you looking for?


Pharmally officials freed after almost 7 months in jail

TWO officials of a company that allegedly sold overpriced medical supplies to the government were released from the Pasay City jail on Thursday after almost seven months.

The Senate sergeant-at-arms released Pharmally Pharmaceutical Corp. Director Linconn Ong and Corporate Secretary Mohit Dargani after Senate President Vicente C. Sotto III signed their release order on Wednesday evening, when Congress adjourned sine die, the Senate said in a statement.

At a hearing last year, the Senate blue ribbon committee asked the officias to submit documents on Pharmally’s dealings with the Budget department’s procurement service. They were cited in contempt and sent to jail after failing to produce the files.

“They have no one but themselves to blame for their continuing detention in the same manner that only their action, their compliance with just directives can pave the way for their release,” Senator Richard J. Gordon, Sr., who heads the committee, said earlier.  

Mr. Gordon has presented a draft report on the body’s findings after its probe of multibillion coronavirus pandemic contracts. Only nine senators have signed the committee report, short of the 11 needed for it to be discussed in plenary.

“There is so much ballyhoo,” Mr. Gordon said in a statement. “Why create a blue ribbon committee if the Senate members will not vote?”

Senate Majority Leader Juan Miguel F. Zubiri and Senator Sherwin T. Gatchalian have said they would only sign the committee report if allegations against outgoing President Rodrigo R. Duterte were removed.

Mr. Gordon’s committee in a 113-page report said Mr. Duterte could be held accountable for siding with people involved in the deals.

It also endorsed charges against Health Secretary Francisco T. Duque III, Budget Director Warren Rex Liong, former Budget Undersecretary Lloyd Christopher Lao, former Duterte economic adviser Michael Yang and several Pharmally officials.

Senator Ana Theresia N. Hontiveros-Baraquel has said she would seek a reinvestigation in the next Congress if the report is not discussed in plenary. The body held 18 hearings over seven months. — Alyssa Nicole O. Tan

Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!



REUTERS TRADE Secretary Alfredo E. Pascual’s intention to join more free trade agreements received backing from major business chambers, who declared support for participating...


NATIONAL IRRIGATION ADMINISTRATION PHOTO RELEASE SUBSIDIES provided to government-owned and -controlled corporations (GOCCs) declined by 82.31% year on year to P7.905 billion in May,...


PHILIPPINE STAR/ MICHAEL VARCAS AGRICULTURE and fisheries planning needs to be more “bottom-up” to better meet the needs of farmers and fisherfolk, steering away...


REUTERS ERIC BROTEN had planned to sow about 5,000 acres of corn this year on his farm in North Dakota, but persistent springtime rains...


(First of two parts) Family-run businesses require structures that are necessary to ensure a smooth transition. In the Philippines, the wealth of ultra-high net...


THOUSANDS of supporters of President Ferdinand “Bongbong” R. Marcos, Jr. are unfazed by the rain during a free concert held in Manila on the...

You May Also Like


BW FILE PHOTO GROSS BORROWINGS by the National Government reached P2.6 trillion as of end-September as it continued to raise funds to respond to...


REUTERS By Luz Wendy T. Noble, Reporter The country’s foreign exchange buffers slightly increased as of end-October as the value of the central bank’s...


COVID-19 has had a significant impact on the mental health of Filipinos across different groups all over the archipelago. From frontline workers, parents balancing...

Financial Advisors

The healthcare ecosystem is one that has thrived on the cusp of scientific progress, benefitting enormously from the winds of change in the technological...

Disclaimer: Respect, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2022 Respect Investment. All Rights Reserved.